|
|
VCs Turning Their Noses Up at Chinese CMOs
publication date: Jul 18, 2008
CMOs step in when pharmaceutical companies opt to outsource their manufacturing process in order to improve efficiency and productivity. Usually, this step can prove vital in slashing the costs of small to medium-sized companies, especially those that focus on biological or biotechnological R & D. However, investing in CMOs is associated with several risks, according to pharmaceutical industry experts at the ChinaBio® Investor Forum 2008, held in Shanghai last week. More details...
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|